Company intelligence / Profile preview

Rescale

San Francisco, California, United States

Ownership: Private
Employees: ~250
Development stage: Other

Overview

Rescale provides a digital engineering platform that leverages cloud-based high-performance computing (HPC) and applied AI for the simulation, modeling, and analysis needs of scientific R&D teams, including in life sciences. The platform accelerates development cycles for drug discovery, genomics, and medical device engineering by giving researchers on-demand access to supercomputing resources and specialized software.

Industry: Drug Discovery Services

Partnerships

Amazon Web Services (AWS)Microsoft AzureNVIDIASamsungHitachiApplied MaterialsUniversity of MichiganBionanoMetabiotaAZothBio

Beyond the preview

Go deeper on Rescale.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rescale.

Explore the full profile